Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
New 'Idiopathic Anaphylaxis Yardstick' offers guidance for diagnosis and treatment

New 'Idiopathic Anaphylaxis Yardstick' offers guidance for diagnosis and treatment

Research reveals potential target for therapies to prevent severe allergic reactions

Research reveals potential target for therapies to prevent severe allergic reactions

New study launched to evaluate experimental treatment for food allergy

New study launched to evaluate experimental treatment for food allergy

Use of broad-spectrum antibiotics to treat pneumonia does more harm than good

Use of broad-spectrum antibiotics to treat pneumonia does more harm than good

Novel vaccine against bee sting allergy successfully tested

Novel vaccine against bee sting allergy successfully tested

Food allergy caused by absence of beneficial bacteria in the gut

Food allergy caused by absence of beneficial bacteria in the gut

Treatment guidelines for managing anaphylaxis in children need to be reassessed

Treatment guidelines for managing anaphylaxis in children need to be reassessed

Scientific evidence for and against causal associations for 47 adverse effects after immunization

Scientific evidence for and against causal associations for 47 adverse effects after immunization

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Newly identified skin-gut communication helps illuminate link between food allergy and eczema

Newly identified skin-gut communication helps illuminate link between food allergy and eczema

Researchers identify new allergen responsible for allergy to durum wheat

Researchers identify new allergen responsible for allergy to durum wheat

New study reveals five facts about allergies to vaccines

New study reveals five facts about allergies to vaccines

Five facts to know about penicillin allergy

Five facts to know about penicillin allergy

Gut microbiome may help prevent development of cow's milk allergy

Gut microbiome may help prevent development of cow's milk allergy

Half of all food allergy sufferers are not actually allergic

Half of all food allergy sufferers are not actually allergic

New first-line treatment for peripheral T-cell lymphoma approved by FDA

New first-line treatment for peripheral T-cell lymphoma approved by FDA

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis